⌘K
Loading ticker…
Zevra Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Zevra Therapeutics, Inc. Common Stock (ZVRA) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.8%, relative volume 1.41×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 88, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ZVRA is in a stage 2 uptrend, week 2. Currently in a 12-day base; basing ADR 5.3% (broad 4.9%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 19.8% / 39.3%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ZVRA is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $16M notional. Top 3 carry $35M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $16M |
| IWMiShares Russell 2000 ETF | 0.02% | $13M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| IWOiShares Russell 2000 Growth ETF | 0.03% | $4M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 0.98% | $3M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $867K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZVRA Jan avg: -5.72% median: -6.00% win: 33% σ: 6.03% n: 3 2023-03-02 → 2026-05-29 | ZVRA Feb avg: 5.93% median: 2.17% win: 67% σ: 9.19% n: 3 2023-03-02 → 2026-05-29 | ZVRA Mar avg: -3.84% median: -2.88% win: 50% σ: 8.11% n: 4 2023-03-02 → 2026-05-29 | ZVRA Apr avg: -3.97% median: -1.98% win: 25% σ: 12.52% n: 4 2023-03-02 → 2026-05-29 | ZVRA May avg: 6.37% median: 7.75% win: 75% σ: 10.90% n: 4 2023-03-02 → 2026-05-29 | ZVRA Jun avg: 3.20% median: 3.04% win: 100% σ: 2.10% n: 3 2023-03-02 → 2026-05-29 (current) | ZVRA Jul avg: 18.08% median: 26.11% win: 67% σ: 19.65% n: 3 2023-03-02 → 2026-05-29 | ZVRA Aug avg: 1.14% median: 3.89% win: 67% σ: 18.27% n: 3 2023-03-02 → 2026-05-29 | ZVRA Sep avg: -3.12% median: -4.93% win: 33% σ: 7.24% n: 3 2023-03-02 → 2026-05-29 | ZVRA Oct avg: 5.81% median: 7.04% win: 67% σ: 12.29% n: 3 2023-03-02 → 2026-05-29 | ZVRA Nov avg: 1.18% median: 6.25% win: 67% σ: 16.43% n: 3 2023-03-02 → 2026-05-29 | ZVRA Dec avg: 11.09% median: 6.29% win: 67% σ: 24.46% n: 3 2023-03-02 → 2026-05-29 |